JPMorgan Chase & Co. Issues Positive Forecast for Exponent (NASDAQ:EXPO) Stock Price

Exponent (NASDAQ:EXPO) had its price objective increased by research analysts at JPMorgan Chase & Co. from $90.00 to $100.00 in a research note issued on Friday, Benzinga reports. The firm presently has an “overweight” rating on the business services provider’s stock. JPMorgan Chase & Co.‘s price target suggests a potential upside of 24.60% from the company’s current price.

EXPO has been the topic of a number of other reports. UBS Group set a $72.00 price objective on shares of Exponent and gave the company a “neutral” rating in a research report on Friday, July 31st. Weiss Ratings raised shares of Exponent from a “hold (c-)” rating to a “hold (c)” rating in a research note on Friday, October 9th. Two research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $86.00.

Exponent Trading Up 2.5%

NASDAQ:EXPO traded up $1.95 during trading hours on Friday, hitting $80.26. 773,547 shares of the stock traded hands, compared to its average volume of 520,748. The firm has a market cap of $3.82 billion, a price-to-earnings ratio of 35.99 and a beta of 0.69. Exponent has a fifty-two week low of $51.91 and a fifty-two week high of $83.18. The firm has a 50 day moving average price of $69.97 and a 200 day moving average price of $66.61.

Exponent (NASDAQ:EXPO) last posted its quarterly earnings results on Thursday, October 29th. The business services provider reported $0.64 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.60 by $0.04. The firm had revenue of $173.73 million during the quarter, compared to analyst estimates of $149.64 million. Exponent had a net margin of 17.67% and a return on equity of 31.48%. The company’s quarterly revenue was up 11.7% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.55 earnings per share. Research analysts predict that Exponent will post 2.31 EPS for the current year.

Insider Activity

In other news, CEO Catherine Corrigan sold 1,707 shares of the firm’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $66.28, for a total value of $113,139.96. Following the transaction, the chief executive officer directly owned 129,108 shares in the company, valued at $8,557,278.24. This trade represents a 1.30% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Corporate insiders own 1.70% of the company’s stock.

Institutional Investors Weigh In On Exponent

Institutional investors and hedge funds have recently modified their holdings of the stock. Mitsubishi UFJ Asset Management Co. Ltd. acquired a new position in shares of Exponent in the second quarter valued at $26,000. Public Employees Retirement System of Ohio bought a new stake in Exponent in the second quarter worth approximately $29,000. Bessemer Group Inc. boosted its position in shares of Exponent by 37.1% during the first quarter. Bessemer Group Inc. now owns 717 shares of the business services provider’s stock valued at $47,000 after buying an additional 194 shares during the last quarter. Allworth Financial LP bought a new stake in shares of Exponent in the second quarter valued at approximately $46,000. Finally, Farther Finance Advisors LLC grew its holdings in shares of Exponent by 36.4% during the 3rd quarter. Farther Finance Advisors LLC now owns 959 shares of the business services provider’s stock valued at $63,000 after purchasing an additional 256 shares during the last quarter. Institutional investors and hedge funds own 92.37% of the company’s stock.

Exponent News Roundup

Here are the key news stories impacting Exponent this week:

• Positive Sentiment: Quarterly earnings and revenue topped estimates. Exponent reported third-quarter EPS of $0.64, above the $0.60 consensus estimate and up from $0.55 a year earlier. Revenue reached $173.7 million versus an expected $149.6 million, while year-over-year revenue increased 11.7%. Exponent Tops Q3 Earnings and Revenue Estimates
• Positive Sentiment: Profitability and cash generation remained solid. Reported net income was approximately $30.9 million, operating profit increased sharply, and operating cash flow was $30.9 million. The results indicate improving operating leverage as revenue expands. Exponent Releases Q3 2026 Earnings
• Positive Sentiment: Management raised its 2026 outlook. The improved guidance reinforces investor expectations for continued growth and supports the positive reaction to the earnings release. Exponent Posts Strong Q3 Results
• Positive Sentiment: The company declared a regular quarterly dividend of $0.31 per share. The dividend is payable December 18 to shareholders of record December 4, representing an annualized payout of $1.24 and a yield of roughly 1.5%. Exponent Declares Quarterly Dividend
• Neutral Sentiment: Exponent plans to acquire Crane Building Services & Utilities in a carve-out transaction. The deal could broaden its service offering, although financial terms and expected earnings benefits were not provided. Exponent to Acquire Crane Building Services and Utilities
• Negative Sentiment: Recent insider trading has been weighted toward selling, with 10 reported sales and only one purchase over the past six months. This may create a modest sentiment headwind, though it is less significant than the earnings beat.

Exponent Company Profile

Exponent, Inc is a science and engineering consulting company that helps clients investigate complex technical issues, manage risks, and develop solutions. Its consultants work across disciplines including engineering, materials science, biomechanics, human factors, environmental science, health, data sciences, and economics.

The company provides failure analysis, product safety and testing, accident reconstruction, environmental and health assessments, regulatory support, and expert testimony.